Enliven Therapeutics, Inc. (ELVN)
NASDAQ: ELVN · IEX Real-Time Price · USD
18.63
+1.02 (5.79%)
At close: Mar 27, 2024, 4:00 PM
17.07
-1.56 (-8.37%)
After-hours: Mar 27, 2024, 4:13 PM EDT

Enliven Therapeutics Stock Forecast

Stock Price Forecast

The 1 analyst with a 12-month price forecast for ELVN stock has a target of 27, which predicts an increase of 44.93% from the current stock price of 18.63.

Analyst Consensus: Strong Buy
Target Low Average Median High
Price $27 $27 $27 $27
Change +44.93% +44.93% +44.93% +44.93%
* Price targets were last updated on Mar 29, 2023.

Analyst Ratings

According to 1 stock analyst, the rating for ELVN is "Strong Buy". This means that the analyst believes this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating Mar '23
Strong Buy 1
Buy 0
Hold 0
Sell 0
Strong Sell 0
Total 1

Latest Forecasts

Analyst Firm Rating Rating Action Price Target Upside Date
Jefferies
Jefferies
Strong Buy
Initiates
$27
Strong Buy Initiates $27 +44.93% Mar 29, 2023
TD Cowen
TD Cowen
Buy
Initiates
n/a
Buy Initiates n/a n/a Mar 3, 2023
More Analyst Ratings

Financial Forecast

Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-2.56
from -2.01
EPS Next Year
-2.95
from -2.56
Year 2019202020212022202320242025
Revenue
-------
Revenue Growth
-------
EPS
-133.60-14.12-9.48-12.05-2.01-2.56-2.95
EPS Growth
-------
No. Analysts -----66
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue 20242025
High n/a n/a
Avg n/a n/a
Low n/a n/a

Revenue Growth

Revenue Growth 20242025
High - -
Avg - -
Low - -

EPS Forecast

EPS 20242025
High -2.33 -2.52
Avg -2.56 -2.95
Low -2.74 -3.65

EPS Growth

EPS Growth 20242025
High - -
Avg - -
Low - -
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.